Nicholas Bandarenko III, MD
Director, Transfusion Services
Department / Division
Pathology /
Pathology Clinical Services
Address
DUMC 2928
Durham, NC 27710
Office Telephone
919-681-4666
Fax Telephone
919-681-3081
- MD, Wake Forest University School of Medicine (North Carolina), 1990
- Pathology, Duke University Medical Center, 1995
- Transfusion Medicine/Blood Bank, UNC Hospitals, 1996
- Fellow, College of American Pathologists
Clinical Interests
Blood banking, transfusion medicine, apheresis (donor, therapeutic, cellular therapy), clinical consultation
Research Interests
Blood banking, transfusion medicine, apheresis(donor, therapeutic, cellular therapy), blood components, blood utilization
This physician (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- AHEC
Representative Publications
Stafford-Smith M, Lockhart E, Bandarenko N, Welsby I. Many, but not all, outcome studies support exclusion of female plasma from the blood supply. Expert Rev Hematol. 2010 Oct;3(5):551-8.
(2010)
Abstract
Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH, . Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher. 2010;25(3):83-177.
(2010)
Abstract
Welsby I, Crow J, Bandarenko N, Lappas G, Phillips-Bute B, Stafford-Smith M. A clinical prediction tool to estimate the number of units of red blood cells needed in primary elective coronary artery bypass surgery. Transfusion. 2010 May 28.
(2010)
Abstract
Bennett-Guerrero E, Stafford-Smith M, Waweru PM, Bredehoeft SJ, Campbell ML, Haley NR, Phillips-Bute B, Newman MF, Bandarenko N. A prospective, double-blind, randomized clinical feasibility trial of controlling the storage age of red blood cells for transfusion in cardiac surgical patients. Transfusion. 2009 Jul;49(7):1375-83.
(2009)
Abstract
Zakarija A, Kwaan HC, Moake JL, Bandarenko N, Pandey DK, McKoy JM, Yarnold PR, Raisch DW, Winters JL, Raife TJ, Cursio JF, Luu TH, Richey EA, Fisher MJ, Ortel TL, Tallman MS, Zheng XL, Matsumoto M, Fujimura Y, Bennett CL. Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl. 2009 Feb;(112):S20-4.
(2009)
Abstract
Bandarenko N, Cancelas J, Snyder EL, Hay SN, Rugg N, Corda T, Joines AD, Gormas JF, Pratt GP, Kowalsky R, Rose M, Rose L, Foley J, Popovsky MA. Successful in vivo recovery and extended storage of additive solution (AS)-5 red blood cells after deglycerolization and resuspension in AS-3 for 15 days with an automated closed system. Transfusion. 2007 Apr;47(4):680-6.
(2007)
Abstract
Shaz BH, Winters JL, Bandarenko N, Szczepiorkowski ZM. How we approach an apheresis request for a Category III, Category IV, or noncategorized indication. Transfusion. 2007 Nov;47(11):1963-71.
(2007)
Abstract
Afenyi-Annan A, Bandarenko N. Transfusion practices for patients with sickle cell disease at a major academic medical center. Immunohematology. 2006;22(3):103-7.
(2006)
Abstract
Hay SN, Egan JA, Millward PA, Bandarenko N, Brecher ME. Patterns of platelet response in idiopathic TTP/HUS: frequency of declining platelet counts with plasma exchange and the recognition and significance of a pseudo refractory state. Ther Apher Dial. 2006 Jun;10(3):237-41.
(2006)
Abstract
Bandarenko N, Brecher ME. United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG): multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange. J Clin Apher. 1998;13(3):133-41.
(1998)
Abstract
